We are analyzing https://link.springer.com/article/10.1007/bf01244786.

Title:
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain | Journal of Neural Transmission
Description:
Journal of Neural Transmission - Significant differences in the content of iron (III) and total iron were found in post mortem substantia nigra of Parkinson
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Social Networks
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

iron, google, scholar, brain, parkinsons, disease, article, riederer, content, iii, parkinsonian, youdim, total, sofic, access, mbh, eds, privacy, cookies, journal, neural, substantia, nigra, neurochemistry, springer, york, neurol, nagatsu, rausch, publish, research, search, birkmayer, tyrosine, gehirn, clin, department, würzburg, function, data, information, log, transmission, increased, post, mortem, heinsen, patients, open, discover,

Topics {✒️}

l-dopa-substitution der parkinson-krankheit month download article/chapter l-dopa therapy privacy choices/manage cookies related subjects full article pdf disease neurotoxicity access die parkinson-krankheit parkinsonian substantia nigra neural transmission aims scope submit manuscript long term consequences aromatic amino acids ciba foundation symposium canadian-american conference phenylethanolamine-n-methyltransferase ferrozine-based reagent movement disorders conditions privacy policy european economic area early iron deficiency iron-rich areas tyrosine hydroxylase activity postmortem parkinsonian brain brain tyrosine hydroxylase accepting optional cookies parkinsonian patients compared age matched controls journal finder publish adrenal tyrosine hydroxylase human brain contents total iron content oxygen free radicals brain iron metabolism youdim rights check access instant access substantia nigra article journal neural transmission 74 article log increased iron der zukunft youdim mbh privacy policy personal data neural transm 67 books a article cite article sofic

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
         description:Significant differences in the content of iron (III) and total iron were found in post mortem substantia nigra of Parkinson's disease. There was an increase of 176% in the levels of total iron and 255% of iron (III) in the substantia nigra of the parkinsonian patients compared to age matched controls. In the cortex (Brodmann area 21), hippocampus, putamen, and globus pallidus there was no significant difference in the levels of iron (III) and total iron. Thus the changes in total iron, iron (III) and the iron (II)/iron (III) ratio in the parkinsonian substantia nigra are likely to be involved in the pathophysiology and treatment of this disorder.
         datePublished:
         dateModified:
         pageStart:199
         pageEnd:205
         sameAs:https://doi.org/10.1007/BF01244786
         keywords:
            Total iron
            iron (III)
            iron (II)
            iron (II)/iron (III) ratio
            Parkinson's disease
            neurotoxicity
            Neurology
            Psychiatry
            Neurosciences
         image:
         isPartOf:
            name:Journal of Neural Transmission
            issn:
               1435-1463
               0300-9564
            volumeNumber:74
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:E. Sofic
               affiliation:
                     name:University of Würzburg
                     address:
                        name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:P. Riederer
               affiliation:
                     name:University of Würzburg
                     address:
                        name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:H. Heinsen
               affiliation:
                     name:University of Würzburg
                     address:
                        name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:H. Beckmann
               affiliation:
                     name:University of Würzburg
                     address:
                        name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:G. P. Reynolds
               affiliation:
                     name:University of Nottingham
                     address:
                        name:Department of Pathology, University of Nottingham, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:G. Hebenstreit
               affiliation:
                     name:Niederösterreichisches Landeskrankenhaus für Psychiatrie und Neurologie
                     address:
                        name:Niederösterreichisches Landeskrankenhaus für Psychiatrie und Neurologie, Mauer-Öhlig, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. B. H. Youdim
               affiliation:
                     name:Rappaport Family Research Institute, Faculty of Medicine
                     address:
                        name:Department of Pharmacology, Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
      description:Significant differences in the content of iron (III) and total iron were found in post mortem substantia nigra of Parkinson's disease. There was an increase of 176% in the levels of total iron and 255% of iron (III) in the substantia nigra of the parkinsonian patients compared to age matched controls. In the cortex (Brodmann area 21), hippocampus, putamen, and globus pallidus there was no significant difference in the levels of iron (III) and total iron. Thus the changes in total iron, iron (III) and the iron (II)/iron (III) ratio in the parkinsonian substantia nigra are likely to be involved in the pathophysiology and treatment of this disorder.
      datePublished:
      dateModified:
      pageStart:199
      pageEnd:205
      sameAs:https://doi.org/10.1007/BF01244786
      keywords:
         Total iron
         iron (III)
         iron (II)
         iron (II)/iron (III) ratio
         Parkinson's disease
         neurotoxicity
         Neurology
         Psychiatry
         Neurosciences
      image:
      isPartOf:
         name:Journal of Neural Transmission
         issn:
            1435-1463
            0300-9564
         volumeNumber:74
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:E. Sofic
            affiliation:
                  name:University of Würzburg
                  address:
                     name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:P. Riederer
            affiliation:
                  name:University of Würzburg
                  address:
                     name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:H. Heinsen
            affiliation:
                  name:University of Würzburg
                  address:
                     name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:H. Beckmann
            affiliation:
                  name:University of Würzburg
                  address:
                     name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:G. P. Reynolds
            affiliation:
                  name:University of Nottingham
                  address:
                     name:Department of Pathology, University of Nottingham, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:G. Hebenstreit
            affiliation:
                  name:Niederösterreichisches Landeskrankenhaus für Psychiatrie und Neurologie
                  address:
                     name:Niederösterreichisches Landeskrankenhaus für Psychiatrie und Neurologie, Mauer-Öhlig, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. B. H. Youdim
            affiliation:
                  name:Rappaport Family Research Institute, Faculty of Medicine
                  address:
                     name:Department of Pharmacology, Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Neural Transmission
      issn:
         1435-1463
         0300-9564
      volumeNumber:74
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Würzburg
      address:
         name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
         type:PostalAddress
      name:University of Würzburg
      address:
         name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
         type:PostalAddress
      name:University of Würzburg
      address:
         name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
         type:PostalAddress
      name:University of Würzburg
      address:
         name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
         type:PostalAddress
      name:University of Nottingham
      address:
         name:Department of Pathology, University of Nottingham, Nottingham, UK
         type:PostalAddress
      name:Niederösterreichisches Landeskrankenhaus für Psychiatrie und Neurologie
      address:
         name:Niederösterreichisches Landeskrankenhaus für Psychiatrie und Neurologie, Mauer-Öhlig, Austria
         type:PostalAddress
      name:Rappaport Family Research Institute, Faculty of Medicine
      address:
         name:Department of Pharmacology, Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:E. Sofic
      affiliation:
            name:University of Würzburg
            address:
               name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
               type:PostalAddress
            type:Organization
      name:P. Riederer
      affiliation:
            name:University of Würzburg
            address:
               name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
               type:PostalAddress
            type:Organization
      name:H. Heinsen
      affiliation:
            name:University of Würzburg
            address:
               name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
               type:PostalAddress
            type:Organization
      name:H. Beckmann
      affiliation:
            name:University of Würzburg
            address:
               name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
               type:PostalAddress
            type:Organization
      name:G. P. Reynolds
      affiliation:
            name:University of Nottingham
            address:
               name:Department of Pathology, University of Nottingham, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:G. Hebenstreit
      affiliation:
            name:Niederösterreichisches Landeskrankenhaus für Psychiatrie und Neurologie
            address:
               name:Niederösterreichisches Landeskrankenhaus für Psychiatrie und Neurologie, Mauer-Öhlig, Austria
               type:PostalAddress
            type:Organization
      name:M. B. H. Youdim
      affiliation:
            name:Rappaport Family Research Institute, Faculty of Medicine
            address:
               name:Department of Pharmacology, Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
      name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
      name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
      name:Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany
      name:Department of Pathology, University of Nottingham, Nottingham, UK
      name:Niederösterreichisches Landeskrankenhaus für Psychiatrie und Neurologie, Mauer-Öhlig, Austria
      name:Department of Pharmacology, Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(68)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.64s.

LINK . SPRINGER . COM {}